Fatty acid synthase expression in squamous cell carcinoma of the tongue: Clinicopathological findings

Oral Diseases

Volumn 14, Issue 4, 2008, Pages 376-382

  Silva, S D ^a   Perez, D E ^a   Nishimoto, I N ^b   Alves, F A ^b   Pinto, C A L ^b   Kowalski, L P ^b   Graner, E ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b A C CAMARGO CANCER CENTER   (Brazil)

Author keywords

Fatty acid synthase; Immunohistochemistry; Oral cancer; Oral squamous cell carcinoma

Indexed keywords

CARBOHYDRATE; CYTOPLASM PROTEIN; FATTY ACID; FATTY ACID SYNTHASE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BLOOD VESSEL INJURY; CANCER GRADING; CANCER INFILTRATION; CANCER STAGING; CLINICAL FEATURE; CORRELATION ANALYSIS; DISEASE COURSE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PERINEURIUM; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; SURVIVAL TIME; TONGUE CARCINOMA;

CARCINOMA, SQUAMOUS CELL; DISEASE PROGRESSION; FATTY ACID SYNTHETASE COMPLEX; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; KAPLAN-MEIERS ESTIMATE; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; TONGUE NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 42149096097     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/j.1601-0825.2007.01395.x     Document Type: Article

References (58)

1. Agostini M, Silva SD, Zecchin KG et al (2004). Fatty acid synthase is required for the proliferation of human oral squamous carcinoma cells. Oral Oncol 40 : 728 735.
2. Almeida JP, Coletta RD, Silva SD et al (2005). Proliferation of fibroblasts cultured from normal gingiva and hereditary gingival fibromatosis is dependent on fatty acid synthase activity. J Periodontol 76 : 272 278.
3. Alo PL, Visca P, Marci A, Mangoni A, Botti C, Di Tondo U (1996). Expression of fatty acid synthase (FAS) as a predictor of recurrence in stage I breast carcinoma patients. Cancer 77 : 474 482.
4. Alo PL, Visca P, Trombetta G et al (1999). Fatty acid synthase (FAS) predictive strength in poorly differentiated early breast carcinomas. Tumori 85 : 35 40.
5. Alo PL, Visca P, Framarino ML et al (2000). Immunohistochemical study of fatty acid synthase in ovarian neoplasms. Oncol Rep 7 : 1383 1388.
6. Baron A, Migita T, Tang D, Loda M (2004). Fatty acid synthase: a metabolic oncogene in prostate cancer? J Cell Biochem 91 : 47 53.
7. Brink J, Ludtke SJ, Yang CY, Gu ZW, Wakil SJ, Chiu W (2002). Quaternary structure of human fatty acid synthase by electron cryomicroscopy. Proc Natl Acad Sci U S A 99 : 138 143.
8. Chirala SS, Chang H, Matzuk M et al (2003). Fatty acid synthesis is essential in embryonic development: fatty acid synthase null mutants and most of the heterozygotes die in utero. Proc Natl Acad Sci U S A 100 : 6358 6363.
9. Dhanasekaran SM, Barrette TR, Ghosh D et al (2001). Delineation of prognostic biomarkers in prostate cancer. Nature 412 : 822 826.
10. Furuya Y, Akimoto S, Yasuda K, Ito H (1997). Apoptosis in androgen independent prostate cell line induced by inhibition of fatty acid synthesis. Anticancer Res 17 : 4589 4593.
11. Gansler TS, Hardman W III., Hunt DA, Schaffel S, Hennigar RA (1997). Increased expression of fatty acid synthase (OA-519) in ovarian neoplasms predicts shorter survival. Hum Pathol 28 : 686 692.
12. Gonzalez-Moles MA, Esteban F, Rodriguez-Archilla A, Ruiz-Avila I, Gonzalez-Moles S (2002). Importance of tumour thickness measurement in prognosis of tongue cancer. Oral Oncol 4 : 394 397.
13. Graner E, Tang D, Rossi S et al (2004). The isopeptidase USP2a regulates the stability of fatty acid synthase in prostate cancer. Cancer Cell 5 : 253 261.
14. Heemers H, Maes B, Foufelle F, Heyns W, Verhoeven G, Swinnen JV (2001). Androgens stimulate lipogenic gene expression in prostate cancer cells by activation of the sterol regulatory element-binding protein cleavage activating protein/sterol regulatory element-binding protein pathway. Mol Endocrinol 10 : 1817 1828.
15. Innocenzi D, Alo PL, Balzani A et al (2003). Fatty acid synthase expression in melanoma. J Cutan Pathol 30 : 23 28.
16. Jackowski S, Wang J, Baburina I (2000). Activity of the phosphatidylcholine biosynthetic pathway modulates the distribution of fatty acids into glycerolipids in proliferating cells. Biochem Biophys Acta 3 : 301 315.
17. Kridel SJ, Axelrod F, Rozenkrantz N, Smith JW (2004). Orlistat is a novel inhibitor of fatty acid synthase with antitumor activity. Cancer Res 64 : 2070 2075.
18. Krontiras H, Roye GD, Beenken SE et al (1999). Fatty acid synthase expression is increased in neoplastic lesions of the oral tongue. Head Neck 21 : 325 329.
19. Kuhajda FP (2000). Fatty-acid synthase and human cancer: new perspectives on its role in tumor biology. Nutrition 16 : 202 208.
20. Kuhajda FP, Jenner K, Wood FD et al (1994). Fatty acid synthesis: a potential selective target for antineoplastic therapy. Proc Natl Acad Sci U S A 14 : 6379 6383.
21. Kuhajda FP, Pizer ES, Li JN, Mani NS, Frehywot GL, Townsend CA (2000). Synthesis and antitumor activity of an inhibitor of fatty acid synthase. Proc Natl Acad Sci U S A 7 : 3450 3454.
22. Kumar-Sinha C, Ignatoski KW, Lippman ME, Ethier SP, Chinnaiyan AM (2003). Transcriptome analysis of HER2 reveals a molecular connection to fatty acid synthesis. Cancer Res 1 : 132 139.
23. Kurokawa H, Yamashita Y, Takeda S, Zhang M, Fukuyama H, Takahashi T (2002). Risk factors for late cervical lymph node metastases in patients with stage I or II carcinoma of the tongue. Head Neck 8 : 731 736.
24. Kusakabe T, Nashimoto A, Honma K, Suzuki T (2002). Fatty acid synthase is highly expressed in carcinoma, adenoma and in regenerative epithelium and intestinal metaplasia of the stomach. Histopathology 40 : 71 79.
25. Lacasa D, Le Liepvre X, Ferre P, Dugail I (2001). Progesterone stimulates adipocyte determination and differentiation 1/sterol regulatory element-binding protein 1c gene expression: potential mechanism for the lipogenic effect of progesterone in adipose tissue. J Biol Chem 15 : 11512 11516.
26. Lupu R, Menendez JA (2006). Pharmacological inhibitors of fatty acid synthase (FASN)-catalyzed endogenous fatty acid biogenesis: a new family of anti-cancer agents? Curr Pharm Biotechnol 7 : 483 494.
27. Menendez JA, Mehmi I, Verma VA, Teng PK, Lupu R (2004a). Pharmacological inhibition of fatty acid synthase (FAS): a novel therapeutic approach for breast cancer chemoprevention through its ability to suppress Her-2/neu (erbB-2) oncogene-induced malignant transformation. Mol Carcinog 41 : 164 178.
28. Menendez JA, Vellon L, Mehmi I et al (2004b). Inhibition of fatty acid synthase (FAS) suppresses HER2/neu (erbB-2) oncogene overexpression in cancer cells. Proc Natl Acad Sci U S A 101 : 10715 10720.
29. Menendez JA, Oza BP, Atlas E, Verma VA, Mehmi I, Lupu R (2004c). Inhibition of tumor-associated fatty acid synthase activity antagonizes estradiol- and tamoxifen-induced agonist transactivation of estrogen receptor (ER) in human endometrial adenocarcinoma cells. Oncogene 28 : 4945 4958.
30. Menendez JA, Colomer R, Lupu R (2005a). Why does tumor-associated fatty acid synthase (oncogenic antigen-519) ignore dietary fatty acids? Med Hypotheses 64 : 342 349.
31. TM) in breast cancer cells: blockade of cell cycle progression, promotion of apoptotic cell death and PEA3-mediated transcriptional repression of Her2/neu (erbB-2) oncogene. Ann Oncol 8 : 1253 1267.
32. Myers RB, Oelschlager DK, Weiss HL, Frost AR, Grizzle WE (2001). Fatty acid synthase: an early molecular marker of progression of prostatic adenocarcinoma to androgen independence. J Urol 3 : 1027 1032.
33. Oskouian B (2000). Overexpression of fatty acid synthase in SKBR3 breast cancer cell line is mediated via a transcriptional mechanism. Cancer Lett 149 : 43 51.
34. Piyathilake CJ, Frost AR, Manne U et al (2000). The expression of fatty acid synthase (FASE) is an early event in the development and progression of squamous cell carcinoma of the lung. Hum Pathol 31 : 1068 1073.
35. Pizer ES, Wood FD, Pasternack GR, Kuhajda FP (1996a). Fatty acid synthase (FAS): a target for cytotoxic antimetabolites in HL60 promyelocytic leukemia cells. Cancer Res 4 : 745 751.
36. Pizer ES, Wood FD, Heine HS, Romantsev FE, Pasternack GR, Kuhajda FP (1996b). Inhibition of fatty acid synthesis delays disease progression in a xenograft model of ovarian cancer. Cancer Res 56 : 1189 1193.
37. Pizer ES, Chrest FJ, DiGiuseppe JA, Han WF (1998). Pharmacological inhibitors of mammalian fatty acid synthase suppress DNA replication and induce apoptosis in tumor cell lines. Cancer Res 20 : 4611 4615.
38. Pizer ES, Thupari J, Han WF et al (2000). Malonyl-coenzyme-A is a potential mediator of cytotoxicity induced by fatty-acid synthase inhibition in human breast cancer cells and xenografts. Cancer Res 2 : 213 218.
39. Pizer ES, Pflug BR, Bova GS, Han WF, Udan MS, Nelson JB (2001). Increased fatty acid synthase as a therapeutic target in androgen-independent prostate cancer progression. Prostate 2 : 102 110.
40. Rossi S, Graner E, Febbo P et al (2003). Fatty acid synthase expression defines distinct molecular signatures in prostate cancer. Mol Cancer Res 1 : 707 715.
41. Rossi S, Ou W, Tang D et al (2006). Gastrointestinal stromal tumours overexpress fatty acid synthase. J Pathol 209 : 369 375.
42. Sebastiani V, Visca P, Botti C et al (2004). Fatty acid synthase is a marker of increased risk of recurrence in endometrial carcinoma. Gynecol Oncol 92 : 101 105.
43. Shurbaji MS, Kalbfleisch JH, Thurmond TS (1996). Immunohistochemical detection of a fatty acid synthase (OA-519) as a predictor of progression of prostate cancer. Hum Pathol 27 : 917 921.
44. Silva SD, Agostini M, Nishimoto IN et al (2004). Expression of fatty acid synthase, ErbB2 and Ki-67 in head and neck squamous cell carcinoma. A clinicopathological study. Oral Oncol 40 : 688 696.
45. Slade RF, Hunt DA, Pochet MM, Venema VJ, Hennigar RA (2003). Characterization and inhibition of fatty acid synthase in pediatric tumor cell lines. Anticancer Res 2 : 1235 1243.
46. Swinnen JV, Esquenet M, Goossens K, Heyns W, Verhoeven G (1997). Androgens stimulate fatty acid synthase in the human prostate cancer cell line LNCaP. Cancer Res 6 : 1086 1090.
47. Swinnen JV, Heemers H, Deboel L, Foufelle F, Heyns W, Verhoeven G (2000). Stimulation of tumor-associated fatty acid synthase expression by growth factor activation of the sterol regulatory element-binding protein pathway. Oncogene 45 : 5173 5181.
48. Swinnen JV, Roskams T, Joniau S et al (2002). Overexpression of fatty acid synthase is an early and common event in the development of prostate cancer. Int J Cancer 98 : 19 22.
49. Swinnen JV, Van Veldhoven PP, Timmermans L et al (2003). Fatty acid synthase drives the synthesis of phospholipids partitioning into detergent-resistant membrane microdomains. Biochem Biophys Res Commun 4 : 898 903.
50. Takahiro T, Shinichi K, Toshimitsu S (2003). Expression of fatty acid synthase as a prognostic indicator in soft tissue sarcomas. Clin Cancer Res 9 : 2204 2212.
51. Visca P, Alo PL, Del Nonno F et al (1999). Immunohistochemical expression of fatty acid synthase, apoptotic-regulating genes, proliferating factors, and ras protein product in colorectal adenomas, carcinomas, and adjacent nonneoplastic mucosa. Clin Cancer Res 5 : 4111 4118.
52. Visca P, Sebastiani V, Pizer ES et al (2003). Immunohistochemical expression and prognostic significance of FAS and GLUT1 in bladder carcinoma. Anticancer Res 23 : 335 339.
53. Visca P, Sebastiani V, Botti C et al (2004). Fatty acid synthase (FAS) is a marker of increased risk of recurrence in lung carcinoma. Anticancer Res 24 : 4169 4173.
54. Vlad LD, Axiots CA, Merino MJ et al (1999). Fatty acid synthase is highly expressed in aggressive thyroid tumors. Mod Pathol 12, 70.
55. Wahi PN, Cohen B, Luthra UK, Torloni H (1971). Histological typing of oral and oropharyngeal tumours. World Health Organization : Geneva.
56. Weiss L, Hoffmann GE, Schreiber R et al (1986). Fatty-acid biosynthesis in man, a pathway of minor importance. Purification, optimal assay conditions, and organ distribution of fatty-acid synthase. Biol Chem Hoppe Seyler 367 : 905 912.
57. Yuen P, Lam KY, Wei WI et al (2000). A comparison of the prognostic significance of tumor diameter, length, width, thickness, area, volume, and clinicopathological features of oral tongue carcinoma. Am J Surg 2 : 139 143.
58. Zhou W, Simpson PJ, McFadden JM et al (2003). Fatty acid synthase inhibition triggers apoptosis during S phase in human cancer cells. Cancer Res 21 : 7330 7337.